Search results
CDC advisory panel votes to recommend the Novavax COVID-19 vaccine
The Today Show via AOL· 2 years agoA Centers for Disease Control and Prevention advisory panel voted Tuesday to recommend Novavax’s...
CDC recommends Novavax COVID vaccine after unanimous vote
CBS News via Yahoo News· 2 years agoA panel of the Centers for Disease Control and Prevention's outside vaccine advisers voted...
Novavax's (NVAX) COVID-19 Jab Gets Approval in Switzerland
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in...
Why Novavax's (NVAX) COVID Vaccine Struggles for Market Share?
Zacks via Yahoo Finance· 2 years agoDespite being the first protein-based COVID-19 vaccine in many markets, Novavax's (NVAX) delayed...
COVID-19 vaccine maker Novavax to chop workforce, expenses
Associated Press via Yahoo News· 12 months agoNovavax is cutting about a quarter of its global workforce as the COVID-19 vaccine maker seeks to...
FDA OKs new COVID-19 shot from Novavax
LA Times via Yahoo News· 2 years agoVials of Novavax's COVID-19 vaccines wait to be labeled at a manufacturing facility in India. The Food and Drug Administration has cleared the vaccine...
FDA, CDC greenlight Novavax's original COVID-19 vaccine as booster
Yahoo Finance via AOL· 2 years agoThe FDA and CDC greenlit Novavax's (NVAX) original COVID-19 vaccine for use as a booster in some...
Health Canada approves updated Novavax vaccine to protect against COVID-19
CBC via Yahoo Sports· 5 months agoHealth Canada has authorized an adapted vaccine from Novavax to prevent COVID-19 in people age 12...
EMA Panel Endorses Novavax's (NVAX) COVID Jab for Full Approval
Zacks via Yahoo Finance· 11 months agoNovavax's (NVAX) protein-based COVID-19 vaccine gets recommendation for full marketing authorization...
Novavax tumbles 30% as waning COVID-19 vaccine demand hits outlook
Reuters via Yahoo Finance· 2 years agoDemand for its vaccine is also waning in the United States, where it was authorized for use among...
